The Australian Pesticides and Veterinary Medicines Authority has shown a sustained improvement in timeframe performance in the June quarter, with 100% of product applications for veterinary medicines completed within timeframe.
“The independent regulator has been working with industry since the beginning of the COVID-19 pandemic to ensure that applications, scientific risk-based assessments and the strong regulatory system continue throughout this disruptive period,” Executive Director of Animal Medicines Australia Ben Stapley said.
“The staff at the APVMA play a critical role in ensuring registered veterinary products are safe and effective. These registered products are essential to protect animal health and welfare and to promote productivity.
“We know that we can’t expect 100% timeframe performance every quarter. However, the sustained, improved results show how well the regulator is currently working.
“This has been a difficult time for many industries. The latest performance report shows the regulator has risen to the challenge and continued to deliver a strong regulatory environment for livestock producers and pet owners.
“Throughout the pandemic farmers have been working hard to put food on the table and pet ownership has now increased to 69% of households. The importance of the APVMA hitting their performance targets has never been more important.
“The animal health industry will continue to work with the independent regulator and policy makers on operational improvements to the regulatory system, but it is clear this system has improved operations and is in the best shape it has been in years.”
The APVMA performance results for the June quarter can be viewed here.